These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 10984368
1. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma. Kemp JP, Berkowitz RB, Miller SD, Murray JJ, Nolop K, Harrison JE. J Allergy Clin Immunol; 2000 Sep; 106(3):485-92. PubMed ID: 10984368 [Abstract] [Full Text] [Related]
2. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma. Corren J, Berkowitz R, Murray JJ, Prenner B. Int J Clin Pract; 2003 Sep; 57(7):567-72. PubMed ID: 14529054 [Abstract] [Full Text] [Related]
3. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. D'Urzo A, Karpel JP, Busse WW, Boulet LP, Monahan ME, Lutsky B, Staudinger H. Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538 [Abstract] [Full Text] [Related]
4. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. Noonan M, Karpel JP, Bensch GW, Ramsdell JW, Webb DR, Nolop KB, Lutsky BN. Ann Allergy Asthma Immunol; 2001 Jan; 86(1):36-43. PubMed ID: 11206236 [Abstract] [Full Text] [Related]
5. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma. Nayak AS, Banov C, Corren J, Feinstein BK, Floreani A, Friedman BF, Goldsobel A, Gottschlich GM, Hannaway PJ, Lampl KL, Lapidus RJ, Lawrence M, Lumry W, Munk Z, Pearlman D, Scardella AT, Schenkel EJ, Segal AT, Segall N, Silverman B, Shneyer L, Nolop KB, Harrison JE. Ann Allergy Asthma Immunol; 2000 Apr; 84(4):417-24. PubMed ID: 10795650 [Abstract] [Full Text] [Related]
6. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma. Karpel JP, Busse WW, Noonan MJ, Monahan ME, Lutsky B, Staudinger H. Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062 [Abstract] [Full Text] [Related]
17. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, Lutsky B. Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813 [Abstract] [Full Text] [Related]
18. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial. Harnest U, Price D, Howes T, Sussman G. J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829 [Abstract] [Full Text] [Related]
19. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE. J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706 [Abstract] [Full Text] [Related]